Divi's Laboratories (NSE:DIVISLAB) Total Operating Expense: ₹34,890 Mil (TTM As of Mar. 2026)


NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
94 GF Score
Price ₹6,713.50
GF Value ₹6,732.51
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Divi's Laboratories Total Operating Expense?

Divi's Laboratories NSE:DIVISLAB -0.59% 94 Total Operating Expense is ₹34,890 Mil as of Mar. 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 94/100 and a GF Value™ of ₹6,732.51 (Fairly Valued). The stock has 5 warning signs investors should review.

Divi's Laboratories's Total Operating Expense for the three months ended in Mar. 2026 was ₹8,980 Mil. Divi's Laboratories's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹34,890 Mil.

Divi's Laboratories Total Operating Expense Related Terms

Divi's Laboratories Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Total Operating Expense Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,335.80 24,600.00 26,950.00 30,690.00 34,890.00

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,250.00 8,370.00 8,670.00 8,870.00 8,980.00
NSE:DIVISLAB
94GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34,890 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹34,890 Mil mean?
Divi's Laboratories (NSE:DIVISLAB) has a Total Operating Expense of ₹34,890 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' Total Operating Expense too high?
Divi's Laboratories' current Total Operating Expense is ₹34,890 Mil. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Total Operating Expense compare to ZTS and UTHR?
Divi's Laboratories' Total Operating Expense of ₹34,890 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current Total Operating Expense is ₹34,890 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,732.51, compared to a current price of ₹6,713.50 — trading 0.3% below its estimated fair value. The current Total Operating Expense is ₹34,890 Mil. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Total Operating Expense is ₹34,890 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be undervalued. The current stock price of ₹6,713.50 is trading 0.3% below its estimated GF Value™ of ₹6,732.51. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • Total Operating Expense: ₹34,890 Mil
  • GF Value™: ₹6,732.51 vs. price of ₹6,713.50 (0.3% below fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score

Get the complete analysis for NSE:DIVISLAB

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,713.50
Price
₹6,732.51
GF Value